In situ hybridization of chromosome 6 on fine-needle aspirates from breast carcinomas: Comparisons of numerical abnormalities and ER/PgR status and staining pattern

Diagnostic Cytopathology

Volumn 16, Issue 5, 1997, Pages 420-424

  Sauer, Torill ^a   Beraki, Kahsai ^a   Jebsen, Peter Wilhelm ^a   Ormerod, Eli ^a   Naess, Oddvar ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

chromosomal numerical aberration; chromosome six; estrogen receptor; in situ hybridization

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CHROMOSOME 6; CHROMOSOME ABERRATION; DISOMY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STAINING;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CELL NUCLEUS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 6; COLORING AGENTS; DIGOXIGENIN; DNA PROBES; FEMALE; HUMANS; IN SITU HYBRIDIZATION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0030909151     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199705)16:5<420::AID-DC7>3.0.CO;2-F     Document Type: Article

References (25)

1. Jensen EV, Jacobsen HI. Basic guides to the mechanism of estrogen action. Recent Progr Horm Res 1962;18:387-414.
2. Manni A. Endocrine therapy of metastatic breast cancer. J Endocrinol Invest 1989;12:357-372.
3. Bloom ND, Tobin EH, Schreibman B, Degenshein GA. The role of progesterone receptors in the management of advanced breast cancer. Cancer 1980;45:2992-2997.
4. Fuqua SAW, Fitzgerald SD, Allred DC et al. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 1992;52:483-186.
5. Scott GK, Kushner P, Vigne J-L, Benz CC. Truncated forms of DNA-binding estrogen receptors in human breast cancer. J Clin Invest 1991;88:700-706.
6. McGuire WL, Chamness GC, Fuqua SA. The importance of normal and abnormal oestrogen receptor in breast cancer (review). Cancer Surv 1992;14:31-40.
7. Ince BA, Zhuang Y, Wrenn CK, Shapiro DJ, Katzenellenbogen BS. Powerful dominant negative mutants of the human estrogen receptor. J Biol Chem 1993;268(19):14026-14032.
8. Wei LL. Transcriptional activation of the estrogen receptor (review). Clin Chem 1993;39(2):341-345.
9. Leslie KK, Tasset DM, Horwitz KB. Functional analysis of a mutant estrogen receptor isolated from T47Dco breast cancer cells. Am J Obstet Gynecol 1992;166(4):1053-1061.
10. Wang Y, Miksicek RJ. Identification of a dominant negative form of the human estrogen receptor. Mol Endocrinol 1991;5(11):1707-1715.
11. Fuqua SA, Chamness GC, McGuire WL. Estrogen receptor mutations in breast cancer (review). J Cell Biochem 1993;51(2):135-139.
12. Fuqua SA, Allred DC, Elledge RM et al. The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations in the DNA binding domain. Breast Cancer Res Treat 1993;26(2)191-202.
13. Fuqua SA, Fitzgerald SD, Chamness GC et al. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 1991;51(1):105-109.
14. Watts CK, Handel ML, King RJ, Sutherland RL. Oestrogen receptor gene structure and function of the breast cancer. J Steroid Biochem Mol Biol 1992;41(3-8):529-536.
15. Roodi N, Bailey LR. Kao WY, Verrier CS, Dupont WD, Parl FF. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 1995;87(6): 446-451.
16. Gosden JR, Middleton PG, Rout D. Localization of the human oestrogen receptor gene to chromosome 6q24 - q27 by in situ hybridization. Cytogenet Cell Genet 1986;43(3-4):218-220.
17. Menasce LP, White GR, Harrison CJ, Boyle JM. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 1993;17(1):263-265.
18. Abati A, Sanford JS, Fetsch P, Marincola FM, Wolman SR. Fluorescence in situ hybridization (FISH): a user's guide to optimal preparation of cytologie specimens. Diagn Cytopathol 1995;13(5):486-492.
19. Cajulis RS, Frias-Hidvegi D. Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosomespecific probes. Acta Cytol 1993;37(3):391-396.
20. Sklarew RJ, Wali R, Auger M, Kidd LD, Katz RL. Estrogen receptor immunostaining patterns imaged in breast cancer fine needle aspirates. Analyt Quant Cytol Histol 1994;16(4):293-305.
21. Sauer T, Naess O, Kåresen R, Jacobsen U, Amlie E, Haug E. Determination of oestrogen receptors in breast carcinomas. Tidsskr Nor Laegeforen 1994;114:1053-1055.
22. Nembrot M, Quintana B, Mordoh J. Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors. Biochem Biophys Res Commun 1990;166(2):601-607.
23. Devilee P, van Vlit M, van Sloun P et al. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 1991;6:1705-1711.
24. Magdelat H, Gerbault-Serau M, Dutrillaux B. Relationship between loss of estrogen and progesterone receptor expression and of 6q and 11q chromosome arms in breast cancer, Int J Cancer 1994;57(1):63-66.
25. Sauer T et al. Ploidy analysis by in situ hybridization of fine needle aspirates from breast carcinomas. Correlation with cytologic grading. Diagn Cytopathol, in press.